use of melatonin agonists such as indole derivatives for treating benign prostatic hyperplasia

摘要

Melatonin agonists are used in the preparation of a medicament for treating benign prostatic hyperlasia in a mammal. The preferred melatonin agonist is N-[2-(substituted-3-indolyl)ethyl]amide such as N-[2-methyl-2-(5-methoxy-6-chloroindol-3-yl)ethyl]acetamide.